Prognostic factors in advanced gastric cancer patients receiving cytotoxic chemotherapy
Queisser, W.
Journal Of Cancer Research and Clinical Oncologyuppl: S85
1986
DOI: 10.1007/bf02580110
Accession: 028976796
PDF emailed within 0-6 h: $19.90
Related References
M.E.H.im; L.E.ler; T.B.ummer; W.Q.eier 1986: Prognostic factors of advanced colorectal cancer patients receiving cytotoxic chemotherapy Journal of Cancer Research and Clinical Oncology 111(1 Suppl): S95-S0Yu, H.; Xu, L.; Yin, S.; Jiang, J.; Hong, C.; He, Y.; Zhang, C. 2022: Risk Factors and Prognostic Impact of Postoperative Complications in Patients with Advanced Gastric Cancer Receiving Neoadjuvant Chemotherapy Current Oncology 29(9): 6496-6507
Liu, Y.; Ling, Y.; Qi, Q.; Lan, F.; Zhu, M.; Zhang, Y.; Bao, Y.; Zhang, C. 2017: Prognostic value of circulating tumor cells in advanced gastric cancer patients receiving chemotherapy Molecular and Clinical Oncology 6(2): 235-242
Wu, X.; Zhou, F.; Ji, X.; Ren, K.; Shan, Y.; Mao, X.; Fen, Y.; Chen, R.; Ding, H.; Fu, X. 2017: The prognostic role of MAC30 in advanced gastric cancer patients receiving platinum-based chemotherapy Future Oncology 13(29): 2691-2696
Sasaki, T.; Isayama, H.; Nakai, Y.; Togawa, O.; Kogure, H.; Ito, Y.; Yamamoto, K.; Mizuno, S.; Yagioka, H.; Yashima, Y.; Kawakubo, K.; Arizumi, T.; Matsubara, S.; Sasahira, N.; Hirano, K.; Tsujino, T.; Toda, N.; Tada, M.; Omata, M.; Koike, K. 2011: Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy Cancer ChemoTherapy and Pharmacology 67(4): 847-853
Saisho, T.; Okusaka, T.; Ueno, H.; Morizane, C.; Okada, S. 2005: Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy Hepato-Gastroenterology 52(66): 1654-1658
Shoji, H.; Yamada, Y.; Okita, N.; Takashima, A.; Honma, Y.; Iwasa, S.; Kato, K.; Hamaguchi, T.; Shimada, Y. 2015: Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic Significance Anticancer Research 35(9): 5055-5061
Kimura, M.; Iwai, M.; Usami, E.; Teramachi, H.; Yoshimura, T. 2018: Prognostic factors in patients with advanced and recurrent colorectal cancer receiving last-line chemotherapy Die Pharmazie 73(2): 115-119
Li, Y.; Wei, Y.; He, Q.; Wang, X.; Fan, C.; Li, G. 2018: Clinicopathological and prognostic significance of high circulating lymphocyte ratio in patients receiving neoadjuvant chemotherapy for advanced gastric cancer Scientific Reports 8(1): 6223
Akhsan, A.; Aryandono, T. 2010: Prognostic factors of locally advanced breast cancer patients receiving neoadjuvant and adjuvant chemotherapy Asian Pacific Journal of Cancer Prevention: Apjcp 11(3): 759-761
Xu, H.; Zhang, X.; Wu, Z.; Feng, Y.; Zhang, C.; Xie, M.; Yang, Y.; Zhang, Y.; Feng, C.; Ma, T. 2021: Performances of Prognostic Models in Stratifying Patients with Advanced Gastric Cancer Receiving First-line Chemotherapy: a Validation Study in a Chinese Cohort Journal of Gastric Cancer 21(3): 268-278
Kunisaki, C.; Takahashi, M.; Ono, H.A.; Oshima, T.; Takagawa, R.; Kimura, J.; Kosaka, T.; Makino, H.; Akiyama, H.; Endo, I. 2012: Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy Oncology 83(4): 183-191
Lavin, P.T.; Bruckner, H.W.; Plaxe, S.C. 1982: Studies in prognostic factors relating to chemotherapy for advanced gastric cancer Cancer 50(10): 2016-2023
Zha, Y.; Cun, Y.; Zhang, Q.; Li, Y.; Tan, J. 2012: Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy Hepato-Gastroenterology 59(117): 1327-1332
Li, Q.-Q.; Lu, Z.-H.; Yang, L.; Lu, M.; Zhang, X.-T.; Li, J.; Zhou, J.; Wang, X.-C.; Gong, J.-F.; Gao, J.; Li, J.; Li, Y.; Shen, L. 2014: Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy Asian Pacific Journal of Cancer Prevention: Apjcp 15(2): 945-950
Takahashi, H.; Wakui, A. 1988: Prognostic factors affecting survival of advanced gastric cancer patients on cancer chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(8): 2194-2201
Tsujinaka, T.; Shiozaki, H.; Yano, M.; Kikkawa, N.; Takami, M.; Monden, M. 2001: Prognostic factors for recurrence in stage II and III gastric cancer patients receiving a curative resection and postoperative adjuvant chemotherapy Oncology Reports 8(1): 33-38
Ding, P.'a.; Guo, H.; Sun, C.; Yang, P.; Kim, N.H.; Tian, Y.; Liu, Y.; Liu, P.; Li, Y.; Zhao, Q. 2022: Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study Bmc Gastroenterology 22(1): 121
Kou, T.; Kanai, M.; Yamamoto, M.; Xue, P.; Mori, Y.; Kudo, Y.; Kurita, A.; Uza, N.; Kodama, Y.; Asada, M.; Kawaguchi, M.; Masui, T.; Mizumoto, M.; Yazumi, S.; Matsumoto, S.; Takaori, K.; Morita, S.; Muto, M.; Uemoto, S.; Chiba, T. 2016: Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy International Journal of Clinical Oncology 21(1): 118-125
Cui, H.; Zhang, K.C.; Cao, B.; Deng, H.; Liu, G.X.; Cui, J.X.; Xie, T.Y.; Liang, W.Q.; Zhang, Q.P.; Wang, N.; Chen, L.; Wei, B. 2021: Risk factors of postoperative complication after total gastrectomy in advanced gastric cancer patients receiving neoadjuvant chemotherapy Zhonghua Wei Chang Wai Ke Za Zhi 24(2): 153-159